Home > Insider Trading > Filing (0001438133-21-000060)

Filing Details

Accession Number:: 0001438133-21-000060
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-20 21:37:03
Reporting Period:: 2021-05-17

Accepted Time:: 2021-05-20 21:37:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438133	Tandem Diabetes Care Inc	TNDM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1422126	B David Berger	C/O Tandem Diabetes Care, Inc. 11075 Roselle Street San Diego CA 92121	Evp, Chief Business/Compliance	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-05-17	296	$66.76	4,862	No	4	A	Direct
Common Stock	Acquisiton	2021-05-18	243	$73.73	443	No	4	M	Indirect	Berger Family Trust
Common Stock	Disposition	2021-05-18	201	$89.14	242	No	4	S	Indirect	Berger Family Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	M	Indirect	Berger Family Trust
No	4	S	Indirect	Berger Family Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Unit	Acquisiton	2021-05-18	2,599	$0.00	2,599	$0.00
Common Stock	Performance Stock Unit	Acquisiton	2021-05-18	2,599	$0.00	2,599	$0.00
Common Stock	Stock Option	Acquisiton	2021-05-18	7,940	$0.00	7,940	$81.63
Common Stock	Warrant	Acquisiton	2021-05-18	243	$73.73	243	$73.73

Remaning Holdings	Exercise Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,599		No	4	A	Direct
2,599		No	4	A	Direct
7,940		No	4	A	Direct
0	2021-05-18	No	4	M	Indirect

Footnotes

The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 17, 2020 through May 17, 2021. This transaction is also exempt under Rule 16b-3(c).
The transaction reflects the cashless exercise of warrants to purchase common stock, at an exercise price of $73.726. Pursuant to the terms of the warrant, the shares of common stock were sold at a price equal to the average of the closing prices of the shares over the 30-day period ending three days prior to the date on which the notice of exercise was received by the Issuer.
The securities are held by the Berger Family Trust dated April 16, 2008.
Awarded on May 18, 2021 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the "2013 Plan").
Each restricted stock unit ("RSU") represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on the one-year anniversary of the grant date, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter, subject to the terms of the 2013 Plan.
Each performance stock unit ("PSU") represents a contingent right to receive one share of Tandem Diabetes Care, Inc. (the "Company") common stock based upon the achievement of certain pre-defined performance metrics as of December 31, 2024 (the "Measurement Date"). The number of shares issued may range from 0% to 200 % of the amount specified above, based upon (i) Company's actual performance relative to the pre-defined performance metrics, and (ii) subject to the awardee's continuing service through the Measurement Date. If minimum performance metrics are not met, no PSU's will vest.
The option shall vest as to twenty-five percent (25%) of the underlying shares on the one-year anniversary of the grant date, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter, subject to the terms of the 2013 Plan.
The expiration date for these options is 10 years from the date of grant.
The expiration dates for these warrants are August 31, 2021 (135 shares), July 3, 2022 (54 shares) and August 21, 2022 (54 shares).